Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemoglobinopathy control program in Turkey.

Duran Canatan1, M Rifat Kose, Munip Ustundag

  • 1Department of Pediatric Hematology, National Hemoglobinopathy Council and Suleyman Demirel University, Isparta, Turkey. dcanatan@superonline.com

Community Genetics
|April 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of Gazelle Microchip Electrophoresis for Premarital Hemoglobinopathy Screening in Türkiye.

EJHaem·2026
Same author

A Descriptive Preanalytical Survey of Procedures Followed for the Screening of Glucose Dysregulation in Thalassemia Centers: Implications for Clinical Practice and Call for Harmonization.

Mediterranean journal of hematology and infectious diseases·2026
Same author

Difficult Cases in the Diagnosis of Thalassemia Syndromes.

Hemoglobin·2026
Same author

A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies for Adherence Optimization.

Mediterranean journal of hematology and infectious diseases·2025
Same author

Hb Andrew-Minneapolis Variant in a Turkish Family

Turkish journal of haematology : official journal of Turkish Society of Haematology·2023
Same author

The Protective Effects of Pyridoxine on Linezolid-Induced Hematological Toxicity, Hepatotoxicity, and Oxidative Stress in Rats.

Turkish archives of pediatrics·2023
Same journal

Does offering prenatal screening influence pregnant women's attitudes regarding prenatal testing?

Community genetics·2008
Same journal

Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.

Community genetics·2008
Same journal

Family physicians' beliefs about genetic contributions to racial/ethnic and gender differences in health and clinical decision-making.

Community genetics·2008
Same journal

Healthy choices through family history: a community approach to family history awareness.

Community genetics·2008
Same journal

Population estimates of extended family structure and size.

Community genetics·2008
Same journal

A community genetics perspective on consanguineous marriage.

Community genetics·2008
See all related articles

Turkey established a national hemoglobinopathy control program (HCP) to address a significant health issue. Screening 377,339 individuals revealed a 4.3% beta-thalassemia trait average, with regional variations.

Area of Science:

  • Public Health
  • Genetics
  • Hematology

Background:

  • Hemoglobinopathies represent a major health concern in Turkey.
  • Previous efforts lacked a unified national control program.
  • The Turkish National Hemoglobinopathy Council (TNHC) was established under the Ministry of Health (MOH).

Purpose of the Study:

  • To implement a national hemoglobinopathy control program (HCP) in Turkey.
  • To establish a unified registry and control framework for hemoglobinopathies.
  • To address the prevention and treatment of hereditary blood diseases.

Main Methods:

  • Screening of 377,339 healthy subjects across 16 cities.
  • Data collection and analysis of hemoglobinopathy trait frequencies.
  • Development and publication of regulations and guidelines for the national HCP.

Related Experiment Videos

Main Results:

  • Average beta-thalassemia trait frequency was 4.3% nationally.
  • Highest beta-thalassemia trait prevalence (13.1%) in Antalya; highest HbS trait prevalence (10%) in Cukurova.
  • 33 high-risk provinces identified for targeted intervention.

Conclusions:

  • A national hemoglobinopathy control program (HCP) has been initiated in Turkey.
  • The program aims to standardize prevention and treatment strategies.
  • Regional prevalence data informs targeted public health interventions.